Current Partnering and Current Agreements data often appears in the international media. We actively support journalists and editors seeking to access up to date deal data in order to present reviews and trends in the life sciences deal making sector.
If you are an writer, journalist or editor and you need access to the latest life sciences deal data, contact us to discuss your requirements and we will try and assist.
An update to the earlier article on therapeutic antibody deal making activity more »
April 10, 2013 :
If past experience is anything to go by, R&D collaborations in animal health are set to fall in 2013 more »
As a therapeutic, monoclonal antibodies are coming of age in that innovative companies have been persistent in improving upon an already effective therapeutic development strategy more »
March 25, 2013 :
A newsletter from Life Science Ventures (issue 1) – March 2013 more »
March 8, 2013 :
A look at the previous five years of deal trends indicates the decline of the megadeal and the emergence of interesting alternative deal dynamics more »
March 27, 2012 : venture capital
A newsletter from Life Science Ventures – issue 2 – March 2012.
Written by Ted Agres, Contributing Editor for Drug Discovery and Development. more »
September 16, 2011 : oncology, partnering
A newsletter from Life Science Ventures (issue 1) – September 2011. more »
June 28, 2011 : oncology, partnering
Current Agreements has been used as one of the data sources for this article that looks at oncology dealmaking and trends. more »
An article written by Steve Poile on biopharma manufacturing alliances. more »